Janux Therapeutics JANX
NASDAQ JANX
$16.94 +0.36 (+2.17%)
As of: Sep 29, 2026 · 3:59 PM EDT

Janux Therapeutics (JANX) Receivables - Net (2020 - 2026)

Updated

Janux Therapeutics' Receivables - Net came in at $149,000 for Q2 2026, down 99.6% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Receivables - Net (2020 - 2026) Analysis & Trends

At the end of FY2020, Janux Therapeutics' Receivables - Net was $8 million.

  • The Q2 2026 figure represents the lowest quarterly Receivables - Net in data going back to Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Janux Therapeutics 1.01 Bn 1.01 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149,000.00
Mar 31, 2026 35.00 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 519,000.00
Mar 31, 2023 800,000.00
Sep 30, 2022 500,000.00
Jun 30, 2021 400,000.00
Dec 31, 2020 8.00 Mn
API Access

Janux Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=JANX&period=max&api_key=YOUR_API_KEY